JCONX
Price
$30.53
Change
-$0.13 (-0.42%)
Updated
Sep 20 closing price
VIMSX
Price
$71.38
Change
-$0.13 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

JCONX vs VIMSX

Header iconJCONX vs VIMSX Comparison
Open Charts JCONX vs VIMSXBanner chart's image
Janus Henderson Contrarian I
Price$30.53
Change-$0.13 (-0.42%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$71.38
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JCONX vs VIMSX Comparison Chart
Loading...
VS
JCONX vs. VIMSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCONX is a Buy and VIMSX is a Buy.

FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 172B vs. JCONX (4.84B). VIMSX pays higher dividends than JCONX: VIMSX (1.38) vs JCONX (0.48). JCONX was incepted earlier than VIMSX: JCONX (15 years) vs VIMSX (26 years). JCONX is a more actively managed with annual turnover of: 45.00 vs. VIMSX (13.00). VIMSX has a lower initial minimum investment than JCONX: VIMSX (3000) vs JCONX (1000000). VIMSX annual gain was more profitable for investors over the last year : 25.11 vs. JCONX (23.48). VIMSX return over 5 years is better than : 56.75 vs. JCONX (42.76).
JCONXVIMSXJCONX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years26 years-
Gain YTD18.24112.557145%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets4.84B172B3%
Annual Yield % from dividends0.481.3835%
Returns for 1 year23.4825.1194%
Returns for 3 years-1.709.82-17%
Returns for 5 years42.7656.7575%
Returns for 10 years37.86128.2130%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSE10.090.15
+1.51%
Inspired Entertainment
FOUR86.901.01
+1.18%
Shift4 Payments
CALT40.00-0.16
-0.40%
Calliditas Therapeutics AB
BCE35.04-0.15
-0.43%
BCE
ACST2.70-0.08
-2.88%
Acasti Pharma